LoadingLoadingLoadingNet selling: insiders sold $5M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsBuys/Adds (1)
D1 Capital
$228.3M
bought
Sells/Trims (2)
Citadel
$438.2M
trimmed
Millennium
$255.3M
trimmed
No tracked top-trader positions in ISRG right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Oct 20, 2026
Financial period
Q3 2026
Earnings per share
$2.64 expected
Revenue
$2.91B expected
Estimates as of Oct 20, 2026
EPS expected
$2.72 to $3.02
Revenue expected
24 analysts
Last 30 days
Analysts cutting estimates
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 20, 2026 | $3.00 / $2.64Yahoo Finance | +13.61% beat | $3.05B $2.91B expected | +4.88% beat |
| Jun 30, 2026 | Jul 16, 2026 | $2.80 / $2.50Yahoo Finance | +11.86% beat | $2.89B No estimate | Unavailable |
| Mar 31, 2026 | Apr 21, 2026 | $2.50 / $2.11Yahoo Finance | +18.67% beat | $2.77B No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Jan 22, 2026 | $2.53 / $2.27Yahoo Finance | +11.57% beat | $2.87B No estimate | Unavailable |
| Sep 30, 2025 | Oct 21, 2025 | $2.40 / $1.99Alpha Vantage | +20.60% beat | $2.51B No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Jul 22, 2025 | $2.19 / $1.92Alpha Vantage | +14.06% beat | $2.44B No estimateSEC filing | Unavailable |
| Mar 31, 2025 | Apr 22, 2025 | $1.81 / $1.73Alpha Vantage | +4.62% beat | $2.25B No estimateSEC filing | Unavailable |
| Dec 31, 2024 | Jan 23, 2025 | $2.21 / $1.79Alpha Vantage | +23.46% beat | $2.41B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.51B | $2.87B | $2.77B | $2.89B |
| Cost of what it sold | $842.7M | $961.9M | $940.3M | $931.9M |
| Gross profit | $1.66B | $1.90B | $1.83B | $1.96B |
| What it spent | ||||
| Research and development | $329.4M | $352.9M | $361.9M | $370.6M |
| Sales and admin | $573.3M | $687.1M | $613.3M | $617.9M |
| Total operating expenses | $902.7M | $1.04B | $975.2M | $988.5M |
| What was left | ||||
| Operating profit | $759.7M | $864.3M | $855.3M | $971.9M |
| Profit before tax | $855.2M | $955.6M | $940.4M | $1.05B |
| Tax | $146.0M | $156.1M | $114.4M | $231.4M |
| Net profit | $704.4M | $794.8M | $821.5M | $818.1M |
| EBITDA | $1.02B | $1.18B | $1.14B | $1.21B |
This stock is trending upward.
Trend
Constructive
75 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
10,000 PATIENTS ACROSS EUROPE ACCESS ROBOTIC-ASSISTED BRONCHOSCOPY WITH ION ENDOLUMINAL SYSTEM / EARLY ADOPTION OF ION ADVANCES MISSION TO IMPROVE SURVIVABILITY IN LUNG CANCER GLOBALLY
NeutralOct 19How Will Intuitive Surgical Stock React To Its Upcoming Earnings?
NeutralOct 19Intuitive Surgical Earnings: What To Look For From ISRG
Leans bullishOct 18Microbot Medical stock has a negative price-to-earnings ratio of -3.64
NeutralOct 17Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Stock Has Average Price Target of $103.33
NeutralOct 17Intuitive Surgical (ISRG) Stock Price Today, Live Chart & News
NeutralOct 16NextEra Energy Q3 2026 Earnings Preview — October 21, Street Expects $1.17 EPS
NeutralOct 16Intuitive Surgical is Down this Year Despite Double-Digit Growth. Is Its 33x Valuation Still Justified?
NeutralOct 16Each bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
